Klogenix is developing therapeutics that aim to elevate Klotho, a naturally occurring protein, which decreases as we age and in certain diseases. Our drug discovery efforts include leading-edge modalities, that enable either upregulation of endogenous Klotho, or supplementation with exogenous Klotho genetic material. The company has several pending patents. Its initial focus is oncology.
- We are passionate about our mission, we are excited about the research programs we are pursuing
- We make decisions based on facts, we do what we promise, we are transparent in our reporting, we execute our plans while being financially conservative
- We dare to be first in the pursuit of novel therapeutic strategies, we realize that there will be failures along the way and we use these to learn and improve
- We show respect to all of our constituents by being ethical, open, honest and fair